Discover

XBIO
Xenetic Biosciences, Inc.
2.13
2 x 1.59
2 x 2.86
bid
ask
+
0.01
0.47%
2 @ 04:00 PM
2.12 -0.01 (0.47%)
Ytd-1.84%
1y-77.48%
2.13
day range
2.23
2.02
52 week range
9.46
Open2.21Prev Close2.12Low2.13High2.23Mkt Cap4.99M
Vol10.29KAvg Vol87.31KEPS-1.15P/EN/AForward P/E-6.20
Beta2.26Short Ratio0.77Inst. Own2.10%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1550-d Avg3.19200-d Avg2.861yr Est4.00
Income Statement
Total Revenue660.60K
Revenues (USD)660.60K
Gross Profit660.60K
Operating Expenses1.63M
Research and Development Expense552.01K
Selling, General and Administrative Expense1.08M
Operating Income-971.69K
Net Income-929.69K
Net Income Common Stock-929.69K
Net Income Common Stock (USD)-929.69K
Consolidated Income-929.69K
Earnings per Basic Share-0.41
Earnings per Basic Share (USD)-0.41
Earnings per Diluted Share-0.41
Earning Before Interest & Taxes (EBIT)-929.69K
Earning Before Interest & Taxes (USD)-929.69K
Weighted Average Shares2.29M
Weighted Average Shares Diluted2.29M
Balance Sheet
Cash and Equivalents6.47M
Cash and Equivalents (USD)6.47M
Current Assets6.65M
Total Assets6.97M
Current Liabilities894.98K
Total Liabilities894.98K
Accumulated Retained Earnings (Deficit)-201.26M
Accumulated Other Comprehensive Income253.73K
Shareholders Equity6.07M
Shareholders Equity (USD)6.07M
Assets Non-Current313.92K
Trade and Non-Trade Payables322.54K
Cash Flow
Net Cash Flow / Change in Cash & Cash Equivalents-875.49K
Net Cash Flow from Operations-875.49K
Share Based Compensation51.96K